Aridis Pharmaceuticals
CA - Los GatosPharmaceutical
Focus: Aridis Pharmaceuticals is a Los Gatos-based biotech focused on monoclonal antibodies and small molecules targeting infectious diseases and neurology. Founded in 2022, the company operates as an early-stage player in a specialized therapeutic niche.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Aridis Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Aridis Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Aerucin 2.0mg/kg
HealthyClinical Trials (1)
NCT02486770Study of Single Doses of IV Aerucin in Healthy Adults
Phase 1Help build intelligence for Aridis Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.